Moderna - Model mRNA - RNA Platform Technology
Our scientists are developing mRNA medicines to help prevent or treat disease.
-
Most popular related searches
Products Details
At Moderna, we are working on developing and testing new mRNA medicines for a wide range of diseases.
All mRNA medicines start with identifying a protein that is designed to prevent or treat a certain disease.
Our scientists design an mRNA that carries instructions for this protein.
To make mRNA vaccines or therapeutics, our scientists create instructions to make different proteins that could help our body fight infections or prevent diseases.
In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more.
At Moderna, we’ve been working on mRNA medicines for over ten years.
With our technology, we are revolutionizing medicine and developing potential mRNA treatments in shorter periods of time for previously untreatable and emerging diseases.
Our mRNA platform, with its speed, scale, and flexibility, is uniquely suited to tackle current and emerging pathogens that threaten global health.
Our research and design services enable us and our partners to advance new product ideas into development candidates.
Our infrastructure enables rapid supply of thousands of pre-clinical mRNAs for in vitro and in vivo research to accelerate programs from idea to development candidate designation.
Our Research Engine combines proprietary digital drug design tools and a highly automated production facility to enable Moderna to advance mRNA vaccines and therapeutics.
Scientists can select any protein in the human proteome to be engineered or they can design novel proteins. All can be designed to explore previously undiscovered pathways.
Our mRNA DESIGN STUDIO enables rapid design of multiple mRNAs.
As the DIGITAL BIOTECH COMPANY™, we maximize the utility of mRNA in our proprietary, web-based mRNA DESIGN STUDIO.
Protein targeting mRNA tailoring Parallel design Automation platforms
-
Our scientists request mRNAs for a specific protein.
-
The protein target is automatically converted to an initial optimized mRNA sequence.
-
Using our Sequence Designer module, they can tailor entire mRNAs from the 5’-UTR to the coding region to the 3’-UTR based on our ever-improving proprietary learnings.
Across our internally developed and partnered mRNA programs, we are simultaneously advancing mRNA development candidates for many diseases into and through clinical studies.
Our mRNA EARLY DEVELOPMENT ENGINE™ services combine internal and external capabilities for process development, toxicology studies, global regulatory interactions, and clinical study preparation and execution for our mRNA vaccines and therapeutics.
These services are designed to deliver many investigational mRNA vaccines and therapeutics to human proof of concept data.
Customer reviews
No reviews were found for Moderna - Model mRNA - RNA Platform Technology. Be the first to review!